Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 20 January 1978:
Vol. 199. no. 4326, pp. 319 - 322
DOI: 10.1126/science.202029

Articles

Science, Vol 199, Issue 4326, 319-322
Copyright © 1978 by American Association for the Advancement of Science


articles

Guanosine 3',5'-monophosphate: a central nervous system regulator of analgesia

ML Cohn, M Cohn, and PH Taylor

The dibutyryl derivative of guanosine 3',5'-monophosphate (cyclic GMP), administered centrally, totally abolishes response to noxious stimuli without depressing the central nervous system. Analgesic properties of the nucleotide are not reversed by naloxone. Microinjected intracerebrally into different sites, dibutyryl cyclic GMP does not mimic the action of morphine. Pharmacological effects of dibutyryl cyclic GMP suggest that endogenous cyclic GMP modulates an inhibitory pain pathway distinct from that on which morphine acts.





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)